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Abstract: In this paper is presented a brief state of art regarding the multivariable formulation for 
controlling the depth of anaesthesia by means of two intravenously administrated drugs, i.e. Propofol and 
Remifentanil. In a feasibility study of determining a suitable variable to quantify analgesia levels in 
patients undergoing cardiac surgery, the Bispectral index and an electromyogram-based surrogate 
variable are proposed as the controlled variables. The study is carried on in the context of implementing a 
multivariable predictive control algorithm. The simulation results show that such a paradigm is feasible, 
although it does not guarantee perfect knowledge of the analgesia level – in other words, the variable is 
not validated against typical evaluations of the pain levels (eg. clinical scores). 
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1. INTRODUCTION 
General anaesthesia plays an important role in surgery and 
intensive care unit (ICU) and requires critical assessment of 
induced quantities of drugs into the patient (Dumont et al, 
2009). It is characterized by unconsciousness through the 
action of anaesthetics, but also by loss of the ability to 
perceive pain through the action of analgesics. Analgesics 
block the sensation of pain; the hypnotics produce 
unconsciousness, while the muscle relaxants prevent 
unwanted movement of muscle tone. The relationship 
between the hypnotic drug, Propofol, administered during 
general anaesthesia, and BIS (a signal derived from the 
electroencephalogram used to assess the level of 
consciousness during anaesthesia) is widely documented and 
several studies regarding the interaction model of Propofol 
and Remifentanil can be found in the literature (Morley et al, 
2000; Struys et al, 2003; Absalom et al, 2011). 
When inducing and maintaining anaesthesia, 
anaesthesiologists select initial doses based on a variety of 
considerations, they observe the results, and then make 
adjustments based on several factors, at irregularly varying 
intervals. In control engineering terminology, this constitutes 
a closed loop control system, due to the feedback present in 
the observations and interventions of the anaesthesiologist. 
The closed-loop control system is characterized by special 
feature: i) it has a human controller in the loop, and ii) the 
control actions are intermittent and irregular in time due to 
the human controller. 
The purpose of computer-controlled closed-loop systems is to 
formalize the process of observation and intervention as to 
provide better and more accurate control. Such systems use a 
near continuous signal of drug effect, calculate the error 
between the observed value and the specified value (selected 
by the medical staff), and use this error in an algorithm to 
make frequent and regular adjustments to drug administration 
rates. Moreover, some computer-control systems try to 
predict the future drug effect to produce the optimal 
convergence to the desired result (Ionescu et al, 2008; 
Absalom et al, 2011). 
In order to have an accurate feedback control, one or more 
real-time representative measures of the system’s state should 
be available. Ideally, the control actuators or process inputs 
should, with minimal or known delay, cause predictable, 
linear changes in the process. In practice, drug administration 
is an asymmetrical process: we can actively infuse but cannot 
actively remove the drug from the patient. Because the 
relationship between dose and plasma concentration is so 
complex, target-controlled infusion (TCI) systems are a 
logical choice of control actuator, so that the control input is 
a target concentration rather than an infusion rate (Kazama et 
al, 1998; Struys et al, 2003; Absalom et al, 2011). Many 
assumptions underpin the pharmacokinetic models used in 
TCI systems, the predictive accuracy of current models is 
imperfect, and the choice of model for Propofol is often 
controversial (Absalom et al, 2009). 
This paper presents results based on the use of Propofol and 
Remifentanil as anaesthetic, respectively analgesic drugs to 
regulate the depth of anaesthesia (DOA). A first attempt is 
made to provide a variable for the effect of Remifentanil drug 
infusion on the analgesic state of the patient. This is then 
tested in a closed loop control simulation by means of 
applying model based predictive control algorithm. Although 
the simulation results are not validated against external 
clinical scores, the paper can serve as an indicator of the 
challenges one needs to tackle when building a fully 
multivariable model for automated regulation of anaesthesia 
and analgesia. 
 
 
  
 
The paper is organized as follows: the next section introduces 
briefly the state of art for modelling anaesthesia and analgesia 
in a multivariable context. Section 3 describes the derivation 
of the output variable to measure the effect of Remifentanil 
infusions. Section 4 presents the simulation setup, followed 
by the simulation results and discussion. Finally, a conclusion 
section summarizes the main outcome of this paper and 
points to some further directions of research. 
 
2. THE MULTIVARIABLE PARADIGM OF 
AUTOMATED DOA 
For measuring the hypnotic component of anaesthesia, 
various indexes are present, mostly computerized from the 
spontaneous or evoked electroencephalogram (EEG) 
(Absalom et al, 2011). The Bispectral index (BIS) is a single 
composite measure derived from the spontaneous EEG and 
has been proven to have a high sensitivity and specificity to 
measure anaesthetic drug effect (Morley et al, 2000; Struys et 
al, 2003). BIS is now recognized as one of the reference 
measures of DOA for closed loop control purposes (Ionescu 
et al, 2008; Absalom et al 2011; Liu et al, 2011). The 
singular control of the Bispectral index by means of Propofol 
drug infusion using computer-assisted DOA has been already 
established in the literature as advantageous to target-
controlled infusion (open loop) (Struys et al, 2003; Ionescu et 
al, 2008; Dumont et al 2009; Yelneedi et al 2009). Hence, 
this paper will focus on the multivariable paradigm, which 
includes the effect of opioids (i.e. analgesic drugs). 
In contrast to cerebral drug effect produced by hypnotics, an 
accurate measure for analgesia is still lacking. Opioids such 
as fentanyl, alfentanyl and Remifentanil are known to have 
synergistic effect on Propofol (Milne et al, 2003; Kazama et 
al, 1998; Simanski et al, 2009). Since general anaesthesia is 
clinically defined as the balance between hypnosis, analgesia 
and paralysis, it is interesting to study the effect of drug 
interaction (Milne et al, 2003). It has already been shown that 
neuromuscular blockade (i.e. the paralysis component of 
general anaesthesia) is not inter-related to the hypnotic and 
analgesic components (i.e. no drug interaction) (Da Silva et 
al, 2011; Simanski et al, 2009). On the other hand, it has 
been shown that the use of Remifentanil in regulated DOA 
has a sparing effect on Propofol infusion rates, hence with 
much less over-dosage occurrences (Milner et al, 2003). The 
challenge, however, is that these combinatorial effects are 
varying from one patient to another – interpatient variability 
– as well as varying within the same patient – intrapatient 
variability. Often the anaesthetists use a certain drug rate for 
a long period of time (tens of minutes) during similar surgical 
procedures, especially in countries where computer assisted 
DOA is not available. This leads to either under- or over-
dosage in the patient, both having undesired effects. It was 
also found that the concentrations for Propofol for which the 
patient became awake were increasing with the duration of 
drug administration, showing the potential for hysteresis 
(Kazama et al, 1998), thus more challenging from control 
point-of-view. 
While feedback monitoring devices and methods are already 
available on the market for the depth of hypnosis (eg. 
Bispectral Index BIS, Auditory Evoked Potential, WAV), 
there exists no “pain sensor” which measures analgesia 
directly (Absalom et al, 2011; Zikov et al, 2006). However, 
there are several systems for analgesia control reported in the 
literature. Most of them use a surrogate of variables to derive 
a fuzzy-expert system, which may assist the clinical nurse in 
determining the optimal analgesic drug rate. A fuzzy 
analgesia control system for induction, maintenance and 
recovery has been reported in (Schubert et al, 2008), using 
three variables: heart rate, mean arterial pressure and an 
index derived from a (modified) standard deviation of the 
RR-intervals in the electrocardiogram format. Furthermore, a 
control system, which minimizes the risks associated with 
delivery of respiratory depressants to spontaneously 
breathing patients during medical procedures, has been 
proposed in (Caruso et al, 2009). This has been based on 
modelling the respiratory depressant effects of Remifentanil 
by means of pharmacokinetic (PK)-pharmacodynamic (PD) 
models in (Caruso et al, 2009) provided the transcutaneous 
monitoring of partial pressure of carbon dioxide in tidal 
breathing. However, this strategy may fail in the event of 
mechanical ventilation, which alters the nominal depressant 
effect. 
A combination of rule-based controller for Remifentanil 
infusion, based on measurements of mean arterial pressure, 
heart rate and systolic arterial pressure, and a fuzzy-PI 
controller for Propofol infusion, based on pre-determined 
DOA levels, is proposed in (Mahfouf et al, 2005). A 
predictive controller with isoflurane and alfentanil is given in 
(Yelneedi et al, 2010) controlling well four variables: 
bispectral index, mean arterial pressure, end tidal 
concentration and alfetanil concentration. However, from a 
control point of view, the control problem is ill-posed, since 
there are two manipulated variables to control four variables.  
Finally, another approach to use cardio-respiratory surrogate 
variables to measure the level of analgesia led to the 
development of the analgoscore, which proved to be 
successful in a manifold of surgical interventions 
(Hemmerling et al, 2007). Unfortunately, no tests are 
performed on patients undergoing cardiac surgery, where 
these surrogate measures coming from the cardio-respiratory 
variables are obviously biased. 
3.  PROPOSED MULTIVARIABLE CONTEXT 
3.1  Patient Models for Propofol and Remifentanil 
In order to investigate the multivariable formulation from 
figure 1, the pharmacokinetic (PK) models for Propofol and 
Remifentanil are required. Additionally, the interaction 
model represented in figure 1 by the Hill block takes into 
account the synergistic effect of these two drugs on the 
output variable, the Bispectral index (BIS). In figure 2 the 
pharmacokinetic (PK) – pharmacodynamic (PD) blocks 
denote compartmental models. The PK-PD models most 
commonly used for Propofol and Remifentanil are the 4th 
order compartmental models described by Schnider (Schnider 
et al, 1999) and Minto (Minto et al, 1997a,b) respectively. 
The PK-PD models are represented by the following 
equations: 
 
 
  
 
!x1(t) = ! k10 + k12 + k13"# $%x1(t)+ k21x2 (t)+ k31x3(t)+
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     (1) 
where 1x  [mg/ml] denotes the drug concentration in the 
central compartment. The peripheral compartments 2 and 3 
model the drug exchange of the blood with well and poorly 
diffused body tissues. The masses of drug in fast and slow 
equilibrating peripheral compartments are denoted by 2x  and 
3x , respectively. The parameters jik , for i j≠ , denote the 
drug transfer frequency from the thj  to the thi  compartment 
and u(t) [mg/s] is the infusion rate of the anaesthetic drug into 
the central compartment. The parameters ijk of the PK 
models depend on age, weight, height and gender and can be 
calculated for Propofol: 
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where 1lC is the rate at which the drug is cleared from the 
body, and 2lC and 3lC are the rates at which the drug is 
removed from the central compartment to the other two 
compartments by distribution. 
 
Fig. 1. Diagram of the proposed multivariable formulation. 
New Model and Second Output are not determined yet. 
 
Fig. 2: Compartmental model of the patient, where PK 
denotes the pharmacokinetic model and PD denotes the 
pharmacodynamic model. 
Similarly, for Remifentanil: 
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(lbm) for men and women has the following expressions:
2
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respectively, with weight (kg) and height (cm). 
An additional hypothetical effect compartment was 
proposed to represent the lag between drug plasma 
concentration and drug response. The concentration of drug 
in this compartment is represented by ex . The drug transfer 
frequency from the central compartment to the effect site-
compartment is equal to the frequency of drug removal from 
the effect-site compartment: 10 1 0.456  [mine ek k
−= = ]. The 
equation is often referred as the effect-site compartment 
concentration. When considering the effect of two drugs, the 
Hill curve becomes a surface, whose parameters represent the 
synergistic effect of both Propofol and Remifentanil effect 
site compartment concentrations. The concentration-response 
relations of the two drugs can be described by a normalized 
relation: 
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where: Pr Re( ) ( )op mU t U t+ is the combined drug concentration; 
γ(θ) is the steepness of the concentration-response relation at 
ratio θ; U50(θ) is the number of units (U) associated with 50% 
of maximum effect at ratio θ; Emax(θ) is the maximum 
possible drug effect at ratio θ (Minto et al, 2000), with the 
effect-site concentrations Pr ( )e opC t  and Re ( )e mC t  normalized 
to their respective potencies 50,Pr opC  and 50,RemC described 
by: 
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and the ratio of the interacting drugs expressed by: 
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In this formulation, θ represents the concentration ratio of the 
new combined drug and ranges from 0 (Remifentanil only) to 
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1 (Propofol only). According to (Minto et al, 1997a) Emax(θ) 
and E0 are set to 100 and U50(θ) can be expressed by a 
quadratic polynomial: 
2
50 ( ) 1U θ β θ β θ= − ⋅ + ⋅                      (5) 
 
The unknown coefficient β can be estimated from the patient 
data. Since the interaction between the two drugs is supra-
additive (the effect of the two drugs combined is higher than 
the sum of each separate effect), β should be a positive 
number. This means that  
50 ( )U θ  is lower than 1 for any value 
of θ between 0 and 1. To simulate the combined effect of 
Propofol and Remifentanil using the nonlinear expression 
from (2), the following values have been assigned (Nascu et 
al, 2011): ! = 0.22;   ! ! = 0.9;   !!",!"#$ = 3.1;   !!",!"# = 34   (6) 
 
3.2  Proposed Model for the Remifentanil Effect 
There have been several attempts to quantify the effect of 
Remifentanil on the analgesia level during surgery and 
intensive care. Some of these are summarized below. 
Derived electroencephalogram measures: if we increase 
the level of Remifentanil the Cortical Input - a measure of the 
magnitude of cortical input - will significantly decrease. For 
quantifying the Propofol effect, one can use the Cortical State 
– a measure of the responsiveness of cortex - which is 
statistically independent of variations in the effect site 
Reminfentanil levels (Liley et al, 2010). 
Respiratory effect: Remifentanil is a potent ventilatory 
depressant. Simulations demonstrated that Remifentanil 
concentrations well tolerated in the steady state will cause a 
clinically significant hypoventilation following bolus 
administration, confirming the acute risk of bolus 
administration of fast-acting opioids in spontaneously 
breathing patients (Caruso et al, 2009; Pattinson et al, 2009). 
Haemodynamic Effects: Remifentanil induces a dose-
dependent decrease in heart rate, arterial blood pressure and 
cardiac output consistent with µ-opioid agonism (Caruso et 
al, 2009; Mahfouf et al, 2005). 
Central Nervous System: Remifentanil induces dose-
dependent changes in relative cerebral blood flow in areas 
involved in pain processing.  Under Remifentanil/N2O 
anaesthesia, the global cerebral blood flow is reduced 
(Hemmerling et al, 2007). As a consequence, intracranial 
pressure is reduced and autoregulation is preserved. 
BIS derivative: our prior studies (unpublished) indicated that 
this signal is more sensitive to artefacts and it responds faster 
than the BIS signal. This suggests further that if this signal is 
used for feedback information, the control might have over-
dosing effects.  
Electromyography is a technique for evaluating and 
recording the activation signal of muscles. An 
electromyograph detects the electrical potential generated by 
muscle cells when these cells contract, and also when the 
cells are at rest. In this study, the relationship between 
Remifentanil effect-site concentration (CeRemi) and the EMG 
is determined. For this, we make use of an illustrative signal 
measurement from one virtual patient undergoing general 
anaesthesia during intensive care. A scaled variable is 
proposed:  
M =
100 !CeRemi
EMG                            
(7) 
thus M is determined as a function of the concentration of 
Remifentanil and the EMG signals. The concentration of 
Remifentanil versus the new value M is represented in the 
following figure for one patient in figure 3. With a green 
dashed line we have represented the relation between the 
concentration of Remifentanil and M using data measured 
during ICU and with a blue solid line we have the linear 
approximation of this relation. This linear approximation has 
the following formula: 
M = 3.4!CeRemi +0.0063              (8) 
Using this equation and equation (7) we can determine a 
relationship for EMG as a function of concentration of 
Remifentanil: 
EMG =
100 !CeRemi
3.4"CeRemi +0.0063              
(9) 
Figure 4 is used to validate the model for M. With a green 
line we have M calculated using the measured data of EMG 
and CeRemi and with a blue line we have M calculated using 
the linear approximation.  
 
Fig. 3.Representation of CeRemi versus M and the linear 
approximation for the virtual patient 
 
 
Fig. 4. Representation of the identified M and the so-called 
measured M 
 
 
  
 
 
3.3  Extended Prediction Self-Adaptive Control  
In this paper, we apply the EPSAC (Extended Prediction 
Self-Adaptive Control) strategy described in detail in (De 
Keyser, 2003). The EPSAC-MPC (EPSAC - Model 
Predictive Control) is based on a generic process model: 
( ) ( ) ( )y t x t n t= +                       (10) 
The disturbance n(t) includes the effects in the measured 
output y(t) which do not come from the model input u(t) via 
the available model. These non-measurable disturbances have 
a stochastic character with non-zero average value, which can 
be modelled by a coloured noise process: 
1 1( ) ( ) / ( ) ( )n t C q D q e t− −⎡ ⎤= ⋅⎣ ⎦              (11) 
with: e(t) - uncorrelated (white) noise with zero mean value;  
C(q-1) and D(q-1) - monic polynomials in the backward shift 
operator q-1 of orders nc and nd. The disturbance filter
1 1( ) / ( )C q D q− − is defined as a pure integrator, to ensure zero 
steady state error.  
The relationship between u(t) and x(t) is given by the generic 
dynamic system model: 
x(t) = f x(t !1),x(t ! 2),!,u(t !1),u(t ! 2),!"# $%      (12) 
In our case the input applied to the patient, ( )u t , is a vector 
containing the Propofol and Remifentanil delivery rates. The 
prediction model output is not represented by a nonlinear Hill 
curve, but by a linear approximation around the maintenance 
values (i.e. BIS values between 40% and 60%) (Nascu et al, 
2011): 
1 Pr 2 Re( ) ( ) ( )e op d e m dx t m C t T m C t T= ⋅ − + ⋅ −         (13) 
The process output is predicted at time instant t over the 
prediction horizon after the time delay Td, based on the 
measurements available at that moment and the future 
outputs of the control signal. The predicted values of the 
output are: 
( / ) ( / ) ( / )y t k t x t k t n t k t+ = + + +               (14) 
Prediction of x(t+k|t) and of n(t+k|t) can be done respectively 
by recursion of the process model and by using filtering 
techniques on the noise model (11) (De Keyser, 2003). 
In EPSAC for linear models, the future response is 
considered as being the cumulative result of two effects: 
( / ) ( / ) ( / )base opty t k t y t k t y t k t+ = + + +    (15) 
where ( / )basey t k t+ represents: 
• effect of past control {u(t-1), u(t-2), ...} (initial 
conditions at time t); 
• effect of a base future control scenario, called 
base ( | ), 0u t k t k+ ≥ , which is defined a priori; for 
linear systems the choice is irrelevant, a simple choice 
being { }base ( | ) 0, 0u t k t k+ ≡ ≥ ; 
• effect of future (predicted) disturbances n(t+k|t). 
and ( / )opty t k t+ represents: 
• effect of the optimizing future control actions 
{ }( | ), ( 1| ), ( 1| )uu t t u t t u t N tδ δ δ+ + −K  with
base( | ) ( | ) ( | )u t k t u t k t u t k tδ + = + − + . The design 
parameter Nu, called the control horizon (a well-known 
concept in MPC-literature), is considered in this paper 
equal to 1. 
The controller output is obtained by minimizing: 
[ ]
2
1
2( ) ( / ) ( / )
N
k N
J r t k t y t k t
=
= + − +∑U       (16) 
where r(t+k/t) is the desired reference trajectory. The 
detailed formulation is given in (De Keyser, 2003) together 
with a multivariable formulation. 
3.4  Simulation Results 
The simulation of the closed loop control performance is 
performed in the context of using the nonlinear patient 
simulator described in section 3.1. In the predictive control 
algorithm, the prediction model for the patient is a linear 
approximation of the full nonlinear model. This linear 
approximation has been previously described in (Nascu et al, 
2011) and consists of the PKPD model from (1)-(2) with a 
linear approximation of the plane given by (3), i.e. (13) with 
m1=12.83 and m2=7.73. The control algorithm has a sampling 
period of 5 seconds, a prediction horizon of 20 samples. 
 
Fig. 5: Simulation test during the induction phase  
 
Fig. 6: Simulation test during the maintenance phase 
Figure 5 depicts the simulation results during the induction 
phase. Bispectral index and EMG are controlled variables, at 
50%, respectively 29% reference values. The manipulated 
variables are Propofol and Remifentanil. Although fast, the 
controller brings the patient to the desired values without 
overshoot. Recall that in this case, there are significantly 
 
 
  
 
large differences between the nonlinear model of the patient 
simulator and the linear approximation of the prediction 
model.   
For the maintenance phase, a signal with clinically realistic 
disturbances has been applied. This signal has been 
developed and introduced in (Yelneedi et al, 2009). Figure 6 
depicts the results of the disturbance rejection test during 
maintenance phase, where one can also observe the 
disturbance signal applied into the control scheme. The 
performance of the controller is quite good and stable. 
However, some high-peaks are observed in the BIS signal 
output as a result of the high disturbance effect. These peaks 
can be minimized if an adaptive control strategy is 
introduced, resulting in a patient-individualized DOA 
regulation framework. However, the topic of such adaptive 
control scheme is the subject of another paper.  
4. CONCLUSIONS 
In this paper is presented a brief state of art regarding the 
multivariable formulation for controlling the depth of  
anaesthesia by means of two intravenously administrated 
drugs, i.e. Propofol and Remifentanil. In a feasibility study of 
determining a suitable variable to quantify analgesia levels in 
patients undergoing cardiac surgery, the Bispectral index and 
an electromyogram-based surrogate variable are proposed as 
the controlled variables. The study is carried on in the context 
of implementing a multivariable predictive control algorithm. 
The simulation results show that such a paradigm is feasible, 
although it does not guarantee perfect knowledge of the 
clinical analgesia level – in other words, the variable is not 
validated against typical evaluations of the pain levels (eg. 
Clinical scores). This means that the strategy is not yet ready 
for clinical practice. These results can be further improved if 
an adaptive control strategy is introduced, resulting in a 
patient-individualized DOA regulation framework. However, 
the topic of such adaptive control scheme is the subject of 
another paper. 
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